Treatment Information


Melanoma treatment details. Radiation.

Princess Alexandra Hospital, Woolloongabba, Australia.

Survival: monthsCountry:Australia
Toxiciy Grade:4City/State/Province:Woolloongabba
Treatments:RadiationHospital:Princess Alexandra Hospital
Date:Oct 2006


Patients: This phase II study involved 234 patients with malignant melanoma. The median age was 57 years, ranging from 20 to 89. The majority (73%) of patients were men.

Treatment: After surgery, patients received radiation therapy to the nodal basin.

Toxicity: The most common grade Grade 3 toxicity was lymphoedema, occurring in 19% of patients with inguinal/iliac disease site, and 9% of patients with axilla disease site. Other Grade 3 / 4 toxicities were subcutaneous changes, nerve/spinal damage, skin changes, bone/joint changes, and mucositis.

Results: The overall survival was 36% at 5 years. The progression free survival was 27% at 5 years. Median survival times were not reported.

Correspondence: Dr. Bryan H. Burmeister